Real-time
Euronext Paris
05:19:29 2024-06-10 am EDT
|
5-day change
|
1st Jan Change
|
3.025
EUR
|
-1.63%
|
|
-6.06%
|
-54.85%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
242.7
|
358.5
|
312.3
|
204.2
|
165.8
|
105.9
|
-
|
-
|
Enterprise Value (EV)
1 |
203.6
|
361.4
|
325.1
|
208.1
|
165.8
|
170.2
|
211.5
|
234.5
|
P/E ratio
|
-5.7
x
|
-9.93
x
|
-5.13
x
|
-4.4
x
|
-3.09
x
|
-2.24
x
|
-3.11
x
|
-7.26
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
347
x
|
-
|
142
x
|
681
x
|
59.2
x
|
5.05
x
|
2.43
x
|
1.15
x
|
EV / Revenue
|
291
x
|
-
|
148
x
|
694
x
|
59.2
x
|
8.11
x
|
4.85
x
|
2.54
x
|
EV / EBITDA
|
-4.94
x
|
-13.1
x
|
-6.37
x
|
-4.14
x
|
-3.26
x
|
-5.16
x
|
-9.24
x
|
-18.1
x
|
EV / FCF
|
-4.98
x
|
-6.65
x
|
-5.25
x
|
-3.71
x
|
-
|
-3.63
x
|
-5.7
x
|
-15.3
x
|
FCF Yield
|
-20.1%
|
-15%
|
-19%
|
-27%
|
-
|
-27.6%
|
-17.5%
|
-6.52%
|
Price to Book
|
6.24
x
|
47.2
x
|
330
x
|
14.3
x
|
-
|
-1.31
x
|
-0.81
x
|
-0.72
x
|
Nbr of stocks (in thousands)
|
12,590
|
12,667
|
15,349
|
19,581
|
24,742
|
34,453
|
-
|
-
|
Reference price
2 |
19.28
|
28.30
|
20.35
|
10.43
|
6.700
|
3.075
|
3.075
|
3.075
|
Announcement Date
|
2/12/20
|
2/10/21
|
2/16/22
|
2/23/23
|
4/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
0.7
|
-
|
2.2
|
0.3
|
2.8
|
20.98
|
43.62
|
92.25
|
EBITDA
1 |
-41.23
|
-27.58
|
-51.08
|
-50.24
|
-50.82
|
-33
|
-22.9
|
-12.95
|
EBIT
1 |
-42.4
|
-36.4
|
-52.4
|
-51.9
|
-52.5
|
-43.5
|
-35.51
|
-16.26
|
Operating Margin
|
-6,057.14%
|
-
|
-2,381.82%
|
-17,300%
|
-1,875%
|
-207.32%
|
-81.4%
|
-17.63%
|
Earnings before Tax (EBT)
1 |
-44.2
|
-38.9
|
-63.74
|
-55.77
|
-55.57
|
-56.31
|
-46.89
|
-11.68
|
Net income
1 |
-42.6
|
-37
|
-61.9
|
-53.7
|
-53.9
|
-39.6
|
-30.39
|
-16.48
|
Net margin
|
-6,085.71%
|
-
|
-2,813.64%
|
-17,900%
|
-1,925%
|
-188.73%
|
-69.67%
|
-17.86%
|
EPS
2 |
-3.380
|
-2.850
|
-3.970
|
-2.370
|
-2.170
|
-1.375
|
-0.9875
|
-0.4233
|
Free Cash Flow
1 |
-40.89
|
-54.37
|
-61.93
|
-56.12
|
-
|
-46.9
|
-37.1
|
-15.3
|
FCF margin
|
-5,841.96%
|
-
|
-2,815.09%
|
-18,707.67%
|
-
|
-223.55%
|
-85.05%
|
-16.58%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/12/20
|
2/10/21
|
2/16/22
|
2/23/23
|
4/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2020 S2
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2021 S2
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
2025 S1
|
2025 S2
|
2026 S1
|
---|
Net sales
1 |
-
|
-
|
-
|
1.1
|
1.1
|
2.2
|
0.06
|
0.06
|
-
|
-
|
0.3
|
0.6
|
2.244
|
5.49
|
12.61
|
21.92
|
35.39
|
56.78
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-20.6
|
-15.8
|
-25.5
|
-13.38
|
-13.38
|
-26.9
|
-12.54
|
-12.54
|
-25.1
|
-
|
-26.8
|
-
|
-26.62
|
-26.1
|
-25.99
|
-23.54
|
-18.88
|
-10.5
|
Operating Margin
|
-
|
-
|
-
|
-1,216.36%
|
-1,216.36%
|
-1,222.73%
|
-20,900%
|
-20,900%
|
-
|
-
|
-8,933.33%
|
-
|
-1,186.5%
|
-475.41%
|
-206.11%
|
-107.39%
|
-53.35%
|
-18.49%
|
Earnings before Tax (EBT)
|
-21.61
|
-17.3
|
-
|
-18.39
|
-18.39
|
-36.71
|
-13.47
|
-13.47
|
-26.9
|
-
|
-
|
-
|
-27.94
|
-28.11
|
-28.21
|
-25.71
|
-21.18
|
-12.79
|
Net income
|
-20.8
|
-16.2
|
-26.4
|
-17.77
|
-17.77
|
-35.5
|
-13
|
-13
|
-26
|
-
|
-
|
-26.7
|
-27.2
|
-24.69
|
-24.79
|
-23.79
|
-19.27
|
-10.84
|
Net margin
|
-
|
-
|
-
|
-1,615.45%
|
-1,615.45%
|
-1,613.64%
|
-21,666.67%
|
-21,666.67%
|
-
|
-
|
-
|
-4,450%
|
-1,211.94%
|
-449.73%
|
-196.59%
|
-108.53%
|
-54.45%
|
-19.09%
|
EPS
|
-
|
-
|
-1.713
|
-1.140
|
-1.140
|
-2.257
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-0.8200
|
-0.7300
|
-0.6600
|
-0.4800
|
-0.2500
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
9/9/20
|
2/10/21
|
9/15/21
|
9/15/22
|
2/16/22
|
2/16/22
|
9/15/22
|
9/15/22
|
9/15/22
|
2/23/23
|
2/23/23
|
9/25/23
|
4/24/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
2.96
|
12.8
|
3.9
|
-
|
64.3
|
106
|
129
|
Net Cash position
1 |
39.1
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-0.1072
x
|
-0.2506
x
|
-0.0776
x
|
-
|
-1.947
x
|
-4.61
x
|
-9.928
x
|
Free Cash Flow
1 |
-40.9
|
-54.4
|
-61.9
|
-56.1
|
-
|
-46.9
|
-37.1
|
-15.3
|
ROE (net income / shareholders' equity)
|
-143%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
3.090
|
0.6000
|
0.0600
|
0.7300
|
-
|
-2.340
|
-3.780
|
-4.300
|
Cash Flow per Share
2 |
-3.190
|
-4.010
|
-3.240
|
-2.400
|
-
|
-1.120
|
-0.8600
|
-0.3800
|
Capex
1 |
0.65
|
2.33
|
1.76
|
1.75
|
-
|
3.23
|
3
|
3.73
|
Capex / Sales
|
92.68%
|
-
|
80.14%
|
582.67%
|
-
|
15.41%
|
6.88%
|
4.05%
|
Announcement Date
|
2/12/20
|
2/10/21
|
2/16/22
|
2/23/23
|
4/24/24
|
-
|
-
|
-
|
Last Close Price
3.075
EUR Average target price
12.32
EUR Spread / Average Target +300.81% Consensus |
1st Jan change
|
Capi.
|
---|
| -54.85% | 115M | | +16.65% | 133B | | -3.85% | 11.52B | | -4.86% | 8.3B | | -22.44% | 4.69B | | +7.79% | 3.42B | | -17.26% | 2.54B | | -13.36% | 2.03B | | -16.39% | 1.86B | | -31.24% | 1.59B |
Medical Devices & Implants
|